MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease
Nicole Schonrock1, Miriam Matamales, Lars M Ittner
1Stem Cell and Developmental Biology Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia. n.schonrock@victorchang.edu.au
Abstract:
MicroRNAs (miRNAs) are small non-coding RNA regulators of protein synthesis that function as "fine-tuning" tools of gene expression in development and tissue homeostasis. Their profiles are significantly altered in neurodegenerative diseases such as Alzheimer's disease (AD) that is characterized by both amyloid-β (Aβ) and tau deposition in brain. A key challenge remains in determining how changes in miRNA profiles translate into biological function in a physiological and pathological context. The key lies in identifying specific target genes for deregulated miRNAs and understanding which pathogenic factors trigger their deregulation. Here we review the literature about the intricate network of miRNAs surrounding the regulation of the amyloid precursor protein (APP) from which Aβ is derived by proteolytic cleavage. Normal brain function is highly sensitive to any changes in APP metabolism and miRNAs function at several steps to ensure that the correct APP end product is produced and in the right form and abundance. Disruptions in this miRNA regulatory network may therefore alter Aβ production, which in turn can affect miRNA expression.
Insights
MicroRNAs (miRNAs) fine-tune gene expression and are altered in Alzheimer's disease (AD). This review explores how miRNA dysregulation impacts amyloid precursor protein (APP) metabolism and amyloid-beta (Aβ) production in AD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- Altered miRNA profiles are observed in neurodegenerative diseases like Alzheimer's disease (AD).
- AD is characterized by amyloid-beta (Aβ) and tau pathology.
Purpose of the Study:
- To review the literature on the miRNA regulatory network of the amyloid precursor protein (APP).
- To understand how altered miRNA expression affects APP metabolism and Aβ production in AD.
- To identify pathogenic factors that trigger miRNA deregulation in AD.
Main Methods:
- Literature review of studies investigating miRNA regulation of APP.
- Analysis of the functional roles of miRNAs in APP processing.
- Examination of the interplay between Aβ pathology and miRNA expression.
Main Results:
- miRNAs play a crucial role in fine-tuning APP metabolism for normal brain function.
- Disruptions in miRNA networks can lead to altered Aβ production.
- Aβ accumulation may, in turn, influence miRNA expression, creating a feedback loop.
Conclusions:
- The intricate miRNA network is essential for regulating APP and preventing Aβ dyshomeostasis.
- Understanding miRNA deregulation in AD is key to elucidating disease mechanisms.
- Targeting miRNA pathways may offer therapeutic strategies for AD.
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
MicroRNAs
MicroRNAs
MicroRNAs
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...


